Open AccessPostmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Author(s) -
Richard J. Santen,
D. Craig Allred,
Stacy P. Ardoin,
David F. Archer,
Norman F. Boyd,
Glenn D. Braunstein,
Henry Burger,
Graham A. Colditz,
Susan R. Davis,
Marco Gambacciani,
Barbara A. Gower,
Victor W. Henderson,
Wael Jarjour,
Richard H. Karas,
Michael Kleerekoper,
Roger A. Lobo,
Jo Ann E. Manson,
Jo Marsden,
Kathryn A. Martin,
Lisa Martin,
Jo Ann V. Pinkerton,
David R. Rubinow,
Helena Teede,
Diane Thiboutot,
Wulf H. Utian
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism/journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-2509
Subject(s) - grading (engineering) , systematic review , randomized controlled trial , evidence based medicine , medical education , medicine , medline , psychology , alternative medicine , political science , pathology , civil engineering , law , engineering
Our objective was to provide a scholarly review of the published literature on menopausal hormonal therapy (MHT), make scientifically valid assessments of the available data, and grade the level of evidence available for each clinically important endpoint. PARTICIPANTS IN DEVELOPMENT OF SCIENTIFIC STATEMENT: The 12-member Scientific Statement Task Force of The Endocrine Society selected the leader of the statement development group (R.J.S.) and suggested experts with expertise in specific areas. In conjunction with the Task Force, lead authors (n = 25) and peer reviewers (n = 14) for each specific topic were selected. All discussions regarding content and grading of evidence occurred via teleconference or electronic and written correspondence. No funding was provided to any expert or peer reviewer, and all participants volunteered their time to prepare this Scientific Statement.